Somatostatin in the treatment of gastrointestinal bleeding caused by angiodysplasia

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 10, 1996, Pages 1037-1039

  Andersen, M R ^a   Aaseby, J ^a  

^a HERNING HOSPITAL   (Denmark)

Author keywords

angiodysplasia; gastrointestinal bleeding; somatostatin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OCTREOTIDE; PROPRANOLOL; SOMATOSTATIN DERIVATIVE;

ABDOMINAL BLEEDING; ADULT; ANEMIA; ANGIODYSPLASIA; ARTICLE; BLOOD TRANSFUSION; BRADYCARDIA; CASE REPORT; ENDOSCOPY; FEMALE; HUMAN; OCCULT BLOOD; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029793547     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609003126     Document Type: Article

References (6)

1. Harford WV. Gastrointestinal angiodysplasia: clinical features. Endoscopy 1988;20:144-8.
2. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-18.
3. Schwartz J, Rozenfeld V, Habot B. Cessation of recurrent bleeding from gastrointestinal angiodysplasia, after beta blocker treatment in a patient with hypertrophic subaortic stenosis - a case history. Angiology 1992;43:244-8.
4. Torsoli A, Annibale B, Viscardi A, Fave GD. Treatment of bleeding due to diffuse angiodysplasia of the small intestine with somatostatin analogue. Eur J Gastroen Hepatol 1991;3:785-7.
5. Rossini FP, Arrigoni A, Pennazio M. Octreotide in the treatment of bleeding due to angiodysplasia of the small intestine. Am J Gastroenterol 1993;88:1424-7.
6. Lamberts SWJ. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin). Acta Endocrinol 1987;112:41-55.